News
Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights.
13h
Cryptopolitan on MSNU.S. export licensing chaos puts billions in AI chip orders on holdThe U.S. government is delaying the approval of thousands of export license applications, leaving several American companies ...
20h
Cryptopolitan on MSNGoogle drops over 50 DEI groups from funding listGoogle has recently removed over 50 organizations associated with diversity, equity, and inclusion (DEI) from its list of ...
But now, Microsoft just made quantum feel a whole lot less sci-fi. CEO Satya Nadella isn’t pitching a pipe dream, and if you ...
While no one has waved an official chequered flag in the Sino-American race for AI supremacy, the markets are betting that ...
On the surface, China’s enthusiasm for open technologies — a community-driven ecosystem grounded in transparency and ...
None of the price-target hikes were particularly dramatic, but since they came from analysts already bullish on AbbVie, they ...
Arm Holdings (NASDAQ: ARM) felt something like an unwanted limb over the past few days, largely because of an earnings report ...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.39%, and ...
The last day of a busy week ends with the first greater-than-1% move in either direction in more than a month.
On Thursday, AbbVie Inc. (NYSE:ABBV) reported second-quarter 2025 sales of $15.42 billion on Thursday, beating the consensus of $14.98 billion. Sales increased 6.6% on a reported basis or 6.5% on an ...
A handful of IPOs and SPACs debuted this past week, led by software unicorn Figma, which soared +250% in the best first day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results